Journals / Türk Kardiyoloji Derneği Arşivi / 2016 / Cilt: 44 - Sayı: 7

Türkiye'de yüksek cerrahi riskli mitral yetersizlikli olgularda MitraClip ile yapılmış perkütan mitral kapak tamiri serisi: Tek merkez deneyimleri

Single-center experience with percutaneous mitral valve repair using the MitraClip in a high-risk series in Turkey

Pages
561–569
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After 1 year, more than 75% of patients had MR severity of

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Mitral valve regurgitation (MR) is the second most common heart valve disease in Europe.
📊
Key Findings & Data:The present objective was to describe the experience of a single center with MitraClip use in a high-risk series in Turkey.Methods: Between May 2013 and September 2014, 28 highsurgical-risk patients with MR of at least grade 3+ and mean EuroSCORE of 26% underwent MitraClip implantation at our institution.
💡
Conclusion & Impact:After 1 year, more than 75% of patients had MR severity of
🔬Design:Research Article
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Mitral valve regurgitation (MR) is the second most common heart valve disease in Europe. Without intervention, prognosis of severe symptomatic MR is poor. Percutaneous edge-to-edge mitral valve repair with MitraClip is a promising mitral regurgitation treatment technique in select, high-surgical-risk patients. The present objective was to describe the experience of a single center with MitraClip use in a high-risk series in Turkey.Methods: Between May 2013 and September 2014, 28 highsurgical-risk patients with MR of at least grade 3+ and mean EuroSCORE of 26% underwent MitraClip implantation at our institution. In-hospital and follow-up safety and efficacy results are presented.Results: Mean patient age was 58 years, and 75% were male. Grade 3 or 4 MR was present in all patients, and was primarily the result of restrictive functional mitral regurgitation (in 89% of cases). Mean left ventricular ejection fraction (LVEF) was 27% and New York Heart Association (NYHA) classification was III or IV in 89% of the population. Acute procedural success was 89%, with 47% of patients receiving a single clip, 39% receiving 2 clips, and 14% receiving 3 clips. One periprocedural death occurred, and 2 deaths occurred during follow-up (mean: 13.9 months). After 1 year, more than 75% of patients had MR severity of

Özet

Amaç: Mitral kapak yetersizliği (MY) Avrupa'da ikinci en sık görülen kalp kapak hastalığıdır. Girişim yapılmaz ise ciddi semptomlu MY'nin prognozu kötüdür. Perkütan uc uca mitral kapak tamiri, MitraClip sistemi sayesinde yüksek cerrahi riske sahip MY'li hastalarda umut vaat etmektedir. Bu çalışmanın amacı yüksek cerrahi riskli olgularda MitraClip uygulamasının Türkiye'de tek merkeze ait sonuçlarını sunmaktır.Yöntemler: Mayıs 2013 ile Eylül 2014 arasında, MY derecesi en az 3 olan ve ortalama EuroSCORE'u %26 bulunan, yüksek cerrahi riskli 28 hastaya merkezimizde MitraClip yerleştirildi. Hastane içi ve takipteki güvenlik ve etkinlik sonuçları sunuldu.Bulgular: Hastaların ortalama yaşı 58 ve %75'i erkekti. Büyük bölümü (%89) restriktif fonksiyonel MY'den oluşan 3-4 derece MY tüm hastalarda mevcuttu. Ortalama sol ventrikül ejeksiyon fraksiyonu %27 olup hastaların %89'unda NYHA (New York Heart Association) fonksiyonel sınıf III-IV idi. Akut işlem başarısı %89 idi (hastaların %47'sine tek clip, %39'una iki clip ve %14'üne üç clip takılmıştır). Bir hasta işlem çevresi dönemde, iki hasta da takip (ortalama 13.9 ay) esnasında hayatını kaybetti. Ortalama bir yılın üzerindeki takip sonrası hastaların %75'inden fazlasının MY'si

🔖

Cite This Article

BULUT, M., KAYMAZ, C., KILIÇGEDİK, A., AVCI, A., PALA, S., TOPRAK, C., İZGİ, İ. A., İNANIR, M., KIRMA, C., ÖZDEMİR, N., KAHVECİ, G., ESEN, A. M. (2022). Türkiye'de yüksek cerrahi riskli mitral yetersizlikli olgularda MitraClip ile yapılmış perkütan mitral kapak tamiri serisi: Tek merkez deneyimleri. Türk Kardiyoloji Derneği Arşivi, Cilt: 44 - Sayı: 7, 561–569. https://ajindex.com/articles/632588

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Iung B, Baron G, Tornos P, Gohlke-Bärwolf C, Butchart EG, Vahanian A. Valvular heart disease in the community: a Euro- pean experience. Curr Probl Cardiol 2007;32:609-61.
  2. Agricola E, Ielasi A, Oppizzi M, Faggiano P, Ferri L, Cal- abrese A, et al. Long-term prognosis of medically treated pa- tients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail 2009;11:581-7.
  3. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Es- quivias G, Baumgartner H, et al. Guidelines on the manage- ment of valvular heart disease (version 2012). Eur Heart J 2012;33:2451-96.
  4. Robbins JD, Maniar PB, Cotts W, Parker MA, Bonow RO, Gheorghiade M. Prevalence and severity of mitral regur- gitation in chronic systolic heart failure. Am J Cardiol 2003;91:360-2.
  5. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M, La Canna G. The double-orifice technique in mi- tral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 2001;122:674-81.
  6. Maisano F, Caldarola A, Blasio A, De Bonis M, La Canna G, Alfieri O. Midterm results of edge-to-edge mitral valve repair without annuloplasty. J Thorac Cardiovasc Surg 2003;126:1987-97.
  7. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, Vanoverschelde JL, et al. What are the characteristics of pa- tients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358-65.
  8. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (En- dovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54:686-94.
  9. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVER- EST Phase I Clinical Trial. J Am Coll Cardiol 2005;46:2134- 40. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011;364:1395-406.
  10. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart As- sociation Task Force on Practice Guidelines. J Thorac Cardio- vasc Surg 2014;148:1-132.
  11. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C, et al. European Association of Echocardiogr